Together with our strategic partners in China, Biosilu Healthcare generates a tailored solution to accelerate the development of innovative specialty biopharmaceuticals for the Chinese / Asian markets.
Our preferred approach is the generation of dedicated legal entities (joint ventures) built around a specific asset or class of assets. This newly formed legal entity will hold all the rights on this(these) asset(s) for the respective territory. The exact jurisdiction, set-up details etc. can be adjusted to the (specific) needs of our partners and co-investors. This approach allows for a strong alignment interest of all shareholders and transparent and clear governance principles.